These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17902517)

  • 1. Hyperactivity and inattention--a successful response to table coffee.
    Wammanda RD
    Niger J Clin Pract; 2007 Jun; 10(2):182-3. PubMed ID: 17902517
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with central nervous system stimulants. Practical guidelines].
    Hvolby A; Jørgensen JI
    Ugeskr Laeger; 2004 Jan; 166(3):144-8. PubMed ID: 14870640
    [No Abstract]   [Full Text] [Related]  

  • 3. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
    [No Abstract]   [Full Text] [Related]  

  • 5. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 6. New approaches to the management and treatment of attention-deficit/hyperactivity disorder.
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S87-8. PubMed ID: 15352534
    [No Abstract]   [Full Text] [Related]  

  • 7. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.
    Kollins SH; March JS
    Biol Psychiatry; 2007 Nov; 62(9):951-3. PubMed ID: 17950067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of stimulants on Hispanic boys' height and weight.
    Farietta-Murray T; Castellanos D; Katsikas S
    J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):150-1. PubMed ID: 17242617
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of methylphenidate in children with ADHD].
    Lauth B
    Laeknabladid; 2007 Dec; 93(12):823. PubMed ID: 18057471
    [No Abstract]   [Full Text] [Related]  

  • 14. Coffee consumption during pregnancy and the risk of hyperkinetic disorder and ADHD: a prospective cohort study.
    Linnet KM; Wisborg K; Secher NJ; Thomsen PH; Obel C; Dalsgaard S; Henriksen TB
    Acta Paediatr; 2009 Jan; 98(1):173-9. PubMed ID: 18764862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperactivity: a rational strategy.
    Healy E
    Practitioner; 1999 Sep; 243(1602):655-9, 662. PubMed ID: 10715862
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 8-year follow-up study of profiles and predictors of methylphenidate use in a nationwide sample of boys.
    Romano E; Thornhill S; Lacourse E
    J Pediatr; 2009 Nov; 155(5):721-7. PubMed ID: 19643442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving decision making in the treatment of ADHD.
    Vitiello B
    Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.